CRISPR gene therapy shows promise against blood diseases
- PMID: 33299166
- DOI: 10.1038/d41586-020-03476-x
CRISPR gene therapy shows promise against blood diseases
Keywords: CRISPR-Cas9 genome editing; Gene therapy; Genetics.
Comment on
-
CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia.N Engl J Med. 2021 Jan 21;384(3):252-260. doi: 10.1056/NEJMoa2031054. Epub 2020 Dec 5. N Engl J Med. 2021. PMID: 33283989 Clinical Trial.
-
Post-Transcriptional Genetic Silencing of BCL11A to Treat Sickle Cell Disease.N Engl J Med. 2021 Jan 21;384(3):205-215. doi: 10.1056/NEJMoa2029392. Epub 2020 Dec 5. N Engl J Med. 2021. PMID: 33283990 Free PMC article. Clinical Trial.
References
-
- Frangoul, H. et al. N. Engl J. Med. https://doi.org/10.1056/NEJMoa2031054 (2020). - DOI - PubMed
-
- Esrick, E. B. et al. N. Engl J. Med. https://doi.org/10.1056/NEJMoa2029392 (2020). - DOI - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
